24 June 2019

Socially Responsible Licensing at Oncode Institute

Elize Brolsma

Elize Brolsma

Elize is part of Oncode’s communication team. She has over 10 years of experience in the com-munication industry, both for commercial and non-profit organisations. After obtaining her bache-lor and master degree in communication at Utrecht University, Elize worked as a communication professional at a research institute, PR agency, law firm and internet company. She has a strong focus on external communications and Public Relations. At Oncode - together with her colleagues - Elize produces the monthly newsletters for Oncode Investigators & Researchers and the Oncode digital magazine. She publishes content for the Oncode website and is responsible for all social media channels. She enjoys discussing science with researchers and support them in their outreach.

Innovation in health care solutions has been seen to correlate with increased costs, potentially resulting in unaffordable health care in the future. One of the ways that Oncode is planning for sustainable implementation of research outputs from the very beginning is through implementation of the Socially Responsible Licensing policies.

It is important that our research results are translated into an application as quickly as possible. When research institutions work together with commercial parties, then often grant licenses to companies on an invention made by their researchers. In consultation with many partners, The Netherlands Federation of University Medical Centres (NFU) established a working group that formulated ten principles for socially responsible licensing.

Oncode has been part of the working group, formally endorses these principles and will implement these guidelines to make sure new scientific insights will be translated into novel therapies for patients in a responsible way.

You can find the 10 principles for socially responsible licensing here (in Dutch).

Other News

LR Bjorn45
Evidence for safety: stem cell transplants do not lead to changes in the DNA
A new study from the group of Oncode Investigator Ruben van Boxtel shows that stem cell transplants do not lead to changes in the DNA of the donor cells. This conclusion provides important evidence for the safety of this procedure. Stem cell transplants can form part of the treatment for children with certain types of leukemia.
ElizeBrolsma

<span>Elize</span><span>Brolsma</span>

Elize is part of Oncode’s communication team. She has over 10 years of experience in the com-munication industry, both for commercial and non-profit organisations. After obtaining her bache-lor and master degree in communication at Utrecht University, Elize worked as a communication professional at a research institute, PR agency, law firm and internet company. She has a strong focus on external communications and Public Relations. At Oncode - together with her colleagues - Elize produces the monthly newsletters for Oncode Investigators & Researchers and the Oncode digital magazine. She publishes content for the Oncode website and is responsible for all social media channels. She enjoys discussing science with researchers and support them in their outreach.
PSEQ Logo rgb primary
Oncode Institute co-lead of major consortium studying therapy resistance in cancer
90% of people who die from cancer respond well to the first treatment, but the cancer is fatal upon its return. In these cases, the tumor has often become resistant to the treatment that initially worked. PERSIST-SEQ, a new international consortium of academic and industry experts in cancer research, will spend the next 5 years intensively investigating why cancer often returns after treatment.
ElizeBrolsma

<span>Elize</span><span>Brolsma</span>

Elize is part of Oncode’s communication team. She has over 10 years of experience in the com-munication industry, both for commercial and non-profit organisations. After obtaining her bache-lor and master degree in communication at Utrecht University, Elize worked as a communication professional at a research institute, PR agency, law firm and internet company. She has a strong focus on external communications and Public Relations. At Oncode - together with her colleagues - Elize produces the monthly newsletters for Oncode Investigators & Researchers and the Oncode digital magazine. She publishes content for the Oncode website and is responsible for all social media channels. She enjoys discussing science with researchers and support them in their outreach.
Oncode Icons Square 13
New research reveals that the actionable metastatic cancer genome is remarkably stable
A one-time analysis of the entire tumor DNA is almost always sufficient to find all DNA errors that may be relevant for treating metastatic cancer. This is because actionable DNA errors remain remarkably stable over time, despite treatment with drugs. This discovery was made by Oncode Investigator Emile Voest (NKI) and his team at the Netherlands Cancer Institute, with the financial support of Oncode Institute. Their findings are now published in Nature Medicine.
Bianca-OliviaNita

<span>Bianca-Olivia</span><span>Nita</span>